CONTRI, CHIARA
 Distribuzione geografica
Continente #
EU - Europa 104
NA - Nord America 67
AS - Asia 44
AF - Africa 27
SA - Sud America 4
OC - Oceania 3
Totale 249
Nazione #
IT - Italia 85
US - Stati Uniti d'America 64
EG - Egitto 24
SG - Singapore 12
CN - Cina 9
DE - Germania 8
IR - Iran 6
GB - Regno Unito 5
ID - Indonesia 5
BR - Brasile 4
CA - Canada 3
KR - Corea 3
NG - Nigeria 3
AU - Australia 2
CH - Svizzera 2
CZ - Repubblica Ceca 2
IN - India 2
SA - Arabia Saudita 2
TW - Taiwan 2
ES - Italia 1
HK - Hong Kong 1
IL - Israele 1
NZ - Nuova Zelanda 1
PK - Pakistan 1
PT - Portogallo 1
Totale 249
Città #
Albosaggia 24
Cairo 23
Chandler 11
Milan 11
Naples 9
Shanghai 9
Singapore 7
Azusa 5
Dresden 5
Jakarta 5
Livorno 5
Louisville 4
Fairfield 3
Lagos 3
Princeton 3
Augusta 2
Bonn 2
Brno 2
Canobbio 2
Chicago 2
Dhahran 2
Ferrara 2
Latina 2
Manchester 2
Melbourne 2
Montreal 2
Noida 2
Pisa 2
Reggio Emilia 2
Rio de Janeiro 2
Rome 2
São Paulo 2
Torino 2
Turin 2
Venice 2
Yilan 2
Airdrie 1
Ashburn 1
Atrani 1
Bologna 1
Brookline 1
Broomfield 1
Crevalcore 1
Dunedin 1
Ferrara di Monte Baldo 1
Hamburg 1
Houston 1
Ismailia 1
Jerusalem 1
Kilburn 1
Los Angeles 1
Madrid 1
Maia 1
Manduria 1
New Bedfont 1
Pittsburgh 1
Rawalpindi 1
San Antonio 1
San Diego 1
Seoul 1
Urbino 1
Villafranca 1
Wilmington 1
Totale 196
Nome #
PHARMACOLOGICAL CHARACTERIZATION OF NEW MODULATORS OF THE ENDOCANNABINOID SYSTEM: FROM SINGLE TARGET TO MULTI-TARGET COMPOUNDS 154
Adenosine and inflammation: Here, there and everywhere 27
Polypharmacological Approaches for CNS Diseases: Focus on Endocannabinoid Degradation Inhibition 20
Adenosine Receptors in Neuropsychiatric Disorders: Fine Regulators of Neurotransmission and Potential Therapeutic Targets 20
Update on the recent development of allosteric modulators for adenosine receptors and their therapeutic applications 13
Synthesis of Unsymmetrical Squaramides as Allosteric GSK-3β Inhibitors Promoting β-Catenin-Mediated Transcription of TCF/LEF in Retinal Pigment Epithelial Cells 11
Development of potent and selective FAAH inhibitors with improved drug-like properties as potential tools to treat neuroinflammatory conditions 10
Pharmacology of Adenosine Receptors: Recent Advancements 8
Caffeine for Prevention of Alzheimer's Disease: Is the A2A Adenosine Receptor Its Target? 6
Pioneering first-in-class FAAH-HDAC inhibitors as potential multitarget neuroprotective agents 3
Binding and unbinding of potent melatonin receptor ligands: Mechanistic simulations and experimental evidence 2
Totale 274
Categoria #
all - tutte 1.908
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 1.908


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202218 0 0 0 0 0 0 0 7 0 0 8 3
2022/202331 3 5 0 3 2 3 6 2 3 0 3 1
2023/2024203 5 3 4 1 20 0 3 3 4 58 43 59
2024/202522 22 0 0 0 0 0 0 0 0 0 0 0
Totale 274